Remove categories southeast-asia
article thumbnail

Lotus Pharmaceuticals and Teraju Pharma link for marketing in Malaysia

Pharmaceutical Technology

The company confirmed that the alliance is in line with its strategic plan to expand in Southeast Asia. The collaboration will launch a portfolio of products in the therapeutic categories of ophthalmology, cardio-metabolic and oncology, commencing in the fourth quarter of 2023.

97
article thumbnail

Trailing its RSV vaccine rivals, Bavarian Nordic cuts China deal

pharmaphorum

The agreement, which also covers South Korea, Taiwan and certain markets in Southeast Asia, will see Nuance take the lead on a phase 3 trial of the MVA-BN RSV vaccine in China that will run separately to Bavarian Nordics own pivotal trial. The Danish company has received an upfront payment of $12.5 million, with another $212.5